{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:26:31Z","timestamp":1794446791067,"version":"4.9.1"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Molecular events that drive endometriosis (EM) and cause accompanying immune deregulation remain elusive. Our purpose was to identify key pathways involved in lesion formation across diverse populations and to detect transcriptomic changes in eutopic endometrium that accompany EM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched Gene Expression Omnibus and ArrayExpress and performed differential gene expression analysis and a network meta-analysis on nine qualifying datasets. Those contained transcriptomic data on 114 ectopic endometrium samples (EL), 138 eutopic endometrium samples from women with endometriosis (EEM), and 79 eutopic endometrium samples from women without endometriosis (EH). Gene ontology and enrichment analysis were performed in DAVID, Metascape, and Cytoscape, and drug repurposing was done in CMap.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>EEM compared to EH upregulated <jats:italic>CCL21<\/jats:italic> and downregulated <jats:italic>BIRC3<\/jats:italic>, <jats:italic>CEL<\/jats:italic>, and <jats:italic>LEFTY1<\/jats:italic> genes (|log<jats:sub>2<\/jats:sub>FC| &amp;gt; 0.5, <jats:italic>p<\/jats:italic> &amp;lt; 0.05). EL showed increased expression of complement and serpin genes (EL vs. EEM: <jats:italic>C7<\/jats:italic>, logFC = 3.38, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001; <jats:italic>C3<\/jats:italic>, logFC = 2.40, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001; <jats:italic>SERPINE1<\/jats:italic>, logFC = 1.02, <jats:italic>p<\/jats:italic> &amp;lt; 0.05; <jats:italic>SERPINE2<\/jats:italic>, logFC = 1.54, <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and mast cell markers (EL vs. EEM: <jats:italic>CPA3<\/jats:italic>, logFC = 1.54, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001; <jats:italic>KIT<\/jats:italic>, logFC = 0.74, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). Functional enrichment analysis highlighted complement and coagulation, inflammation, angiogenesis, and extracellular matrix remodeling as drivers of endometriosis. Pharmacogenomic analysis indicated Janus kinase (JAK), cyclin-dependent kinase (CDK), and topoisomerase inhibitors as therapy targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest an interplay between complement and coagulation, mast cells, extracellular matrix remodeling, and the JAK\/STAT3 pathway in endometriosis. We underscore the significance of complement C3 and propose JAK inhibitors as therapy candidates. Detected expression differences between EEM and EH are important for the development of diagnosis via endometrial biopsy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1619434","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:28:57Z","timestamp":1751952537000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors\u2014a network meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Monika","family":"Golinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Rycerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matylda","family":"Sobczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jedrzej","family":"Chrzanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Stawiski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz018","article-title":"The endometrial immune environment of women with endometriosis","volume":"25","author":"Vallv\u00e9-Juanico","year":"2019","journal-title":"Hum Reprod Update"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1338","article-title":"Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer","volume":"20","author":"Suryawanshi","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1530\/REP-17-0092","article-title":"High-throughput mRNA sequencing of stromal cells from endometriomas and endometrium","volume":"154","author":"Rekker","year":"2017","journal-title":"Reproduction"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000441911","article-title":"Diagnostic delay of endometriosis in the Netherlands","volume":"81","author":"Staal","year":"2016","journal-title":"Gynecologic Obstetric Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.fertnstert.2011.05.090","article-title":"Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries","volume":"96","author":"Nnoaham","year":"2011","journal-title":"Fertility Sterility"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2019.1603217","article-title":"Diagnostic delay for superficial and deep endometriosis in the United Kingdom","volume":"40","author":"Ghai","year":"2020","journal-title":"J obstetrics gynaecol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17719","article-title":"Patient experiences of endometriosis diagnosis: A mixed methods approach","volume":"131","author":"Requadt","year":"2024","journal-title":"BJOG"},{"key":"B8","doi-asserted-by":"publisher","first-page":"110610","DOI":"10.1016\/j.ejrad.2022.110610","article-title":"Endometriosis: A multimodal imaging review","volume":"158","author":"Quesada","year":"2023","journal-title":"Eur J Radiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2017.05.031","article-title":"Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why","volume":"108","author":"Lessey","year":"2017","journal-title":"Fertility Sterility"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671201","article-title":"Identification and validation of the signatures of infiltrating immune cells in the Eutopic endometrium endometria of women with endometriosis","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the gene expression omnibus (GEO) and bioConductor","volume":"23","author":"Sean","year":"2007","journal-title":"Bioinformatics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v106.i02","article-title":"netmeta: an R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"J Stat Software"},{"key":"B13","unstructured":"DAVID functional annotation bioinformatics microarray analysis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/S41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B16","unstructured":"clue.io"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.07.1060","article-title":"Endometriosis and autoimmune disease: association of susceptibility to moderate\/severe endometriosis with CCL21 and HLA-DRB1","volume":"95","author":"Sundqvist","year":"2011","journal-title":"Fertility Sterility"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-52899-8","article-title":"Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls","volume":"9","author":"Knific","year":"2019","journal-title":"Sci Rep"},{"key":"B19","article-title":"Serpin regulation of fibrinolytic system: implications for therapeutic applications in cardiovascular diseases","volume":"12","author":"Al-Horani","year":"2014","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.622778","article-title":"Serpins in hemostasis as therapeutic targets for bleeding or thrombotic disorders","volume":"7","author":"Bianchini","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/S12916-023-02881-Z","article-title":"The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study","volume":"21","author":"Li","year":"2023","journal-title":"BMC Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-024-03227-4","article-title":"The coagulation status in women of endometriosis with stage IV","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Women\u2019s Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100040","DOI":"10.1016\/j.jeud.2023.100040","article-title":"The link between inflammation and hemostasis in endometriosis: a call for research","volume":"3","author":"Casalechi","year":"2023","journal-title":"J Endometriosis Uterine Disord"},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10735-014-9595-y","article-title":"The intricate role of mast cell proteases and the annexin A1-FPR1 system in abdominal wall endometriosis","volume":"46","author":"Paula","year":"2015","journal-title":"J Mol Histol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2019.01543","article-title":"Mast cells in peritoneal fluid from women with endometriosis and their possible role in modulating sperm function","volume":"10","author":"Borelli","year":"2020","journal-title":"Front Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.961599","article-title":"Estrogen mediates inflammatory role of mast cells in endometriosis pathophysiology","volume":"13","author":"McCallion","year":"2022","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"110476","DOI":"10.1016\/j.biopha.2020.110476","article-title":"Possible involvement of crosstalk between endometrial cells and mast cells in the development of endometriosis via CCL8\/CCR1","volume":"129","author":"Li","year":"2020","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jaip.2017.08.022","article-title":"Chromogranin A is not a biomarker of mastocytosis","volume":"6","author":"Hanjra","year":"2017","journal-title":"J Allergy Clin Immunol In Pract"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1016\/j.jaip.2021.12.031","article-title":"Elevated basal serum tryptase: disease distribution and variability in a regional health system","volume":"10","author":"Waters","year":"2022","journal-title":"J Allergy Clin Immunology: In Pract"},{"key":"B30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/S13046-019-1206-Z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.3892\/ol.2019.10059","article-title":"Inhibition of tumor growth and angiogenesis of tamoxifen-resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor","volume":"17","author":"Kim","year":"2019","journal-title":"Oncol Lett"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/jog.15761","article-title":"Potential drug repurposing of ruxolitinib to inhibit the JAK\/STAT pathway for the treatment of patients with epithelial ovarian cancer","volume":"49","author":"Yunianto","year":"2023","journal-title":"J Obstet Gynaecol Res"},{"key":"B33","unstructured":"Study details | VSV-hIFNbeta-NIS with or without ruxolitinib phosphate in treating stage IV or recurrent endometrial cancer | ClinicalTrials.gov"},{"key":"B34","doi-asserted-by":"publisher","first-page":"gaab016","DOI":"10.1093\/MOLEHR\/GAAB016","article-title":"Tofacitinib alters STAT3 signaling and leads to endometriosis lesion regression","volume":"27","author":"Kotlyar","year":"2021","journal-title":"Mol Hum Reprod"},{"key":"B35","unstructured":"BIRC3 mutation - my cancer genome"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.AAN2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhl\u00e9n","year":"2017","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3069","article-title":"Lefty inhibits in vitro decidualization by regulating P57 and cyclin D1 expressions","volume":"32","author":"Li","year":"2014","journal-title":"Cell Biochem Funct"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.7.2526","article-title":"Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility","volume":"85","author":"Tabibzadeh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab864","article-title":"Two new mutations in the CEL gene causing diabetes and hereditary pancreatitis: how to correctly identify MODY8 cases","volume":"107","author":"El Jellas","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2017.12.001","article-title":"The role of the carboxyl ester lipase (CEL) gene in pancreatic disease","volume":"18","author":"Johansson","year":"2018","journal-title":"Pancreatology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-003127","article-title":"Identification and characterization of novel carboxyl ester lipase gene variants in patients with different subtypes of diabetes","volume":"11","author":"Wu","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B42","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00011-010-0220-6","article-title":"The complement cascade as a mediator of tissue growth and regeneration","volume":"59","author":"Rutkowski","year":"2010","journal-title":"Inflammation Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00672","article-title":"Complement therapeutics in autoimmune disease","volume":"10","author":"Thurman","year":"2019","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220752","article-title":"The role of complement in autoimmune disease-associated thrombotic microangiopathy and the potential for therapeutics","volume":"50","author":"Java","year":"2023","journal-title":"J Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nri.2017.97","article-title":"Complement in cancer: untangling an intricate relationship","volume":"18","author":"Reis","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(87)90194-3","article-title":"Immunoproteins in the endometrium: clinical correlates of the presence of complement fractions C3 and C4","volume":"156","author":"Bartosik","year":"1987","journal-title":"Am J obstetrics gynecology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2021.01.005","article-title":"Insights into the role of complement system in the pathophysiology of endometriosis","volume":"231","author":"Rahal","year":"2021","journal-title":"Immunol Lett"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2020.599117","article-title":"Immunological basis of the endometriosis: the complement system as a potential therapeutic target","volume":"11","author":"Agostinis","year":"2021","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2020.04.005","article-title":"Evaluation of complement system proteins C3a, C5a and C6 in patients of endometriosis","volume":"81","author":"Karadadas","year":"2020","journal-title":"Clin Biochem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-4754-0","article-title":"The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis","volume":"297","author":"Sikora","year":"2018","journal-title":"Arch Gynecology Obstetrics"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2013.11.020","article-title":"Overexpression of complement C5 in endometriosis","volume":"47","author":"Aslan","year":"2014","journal-title":"Clin Biochem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt205","article-title":"Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer","volume":"105","author":"Ajona","year":"2013","journal-title":"J Natl Cancer Institute"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.942368","article-title":"Identification and analysis of novel endometriosis biomarkers via integrative bioinformatics","volume":"13","author":"Bae","year":"2022","journal-title":"Front Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"931273","DOI":"10.3389\/fimmu.2022.931273","article-title":"Inside-out of complement in cancer","volume":"13","author":"Kolev","year":"2022","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00125-012-2462-z","article-title":"Complement C3: an emerging risk factor in cardiometabolic disease","volume":"55","author":"Hertle","year":"2012","journal-title":"Diabetologia"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2000645","DOI":"10.1183\/13993003.00645-2020","article-title":"Complement C3 and allergic asthma: a cohort study of the general population","volume":"57","author":"Vedel-Krogh","year":"2021","journal-title":"Eur Respir J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antib9040061","article-title":"Complement and cancer\u2014A dysfunctional relationship","volume":"9","author":"Thurman","year":"2020","journal-title":"Antibodies"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1339647","article-title":"Potential shared pathogenic mechanisms between endometriosis and inflammatory bowel disease indicate a strong initial effect of immune factors","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/S13046-019-1514-3","article-title":"Complement C3 overexpression activates JAK2\/STAT3 pathway and correlates with gastric cancer progression","volume":"39","author":"Yuan","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.693118\/FULL","article-title":"The inflammatory feed-forward loop triggered by the complement component C3 as a potential target in endometriosis","volume":"12","author":"Agostinis","year":"2021","journal-title":"Front Immunol"},{"key":"B62","article-title":"Evaluation of peripheral blood neutrophils activity in women with endometriosis","volume":"72","author":"Kamer-Bartosi\u0144ska","year":"2001","journal-title":"Ginekologia polska"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2019.08.702","article-title":"Serum albumin and C3 complement levels in endometriosis","volume":"29","author":"Hasan","year":"2019","journal-title":"J Coll Physicians Surgeons\u2013Pakistan : JCPSP"},{"key":"B64","unstructured":"Our science - modulating the complement cascade to develop novel therapeutics | Apellis pharmaceuticals"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-01-0711","article-title":"Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin","volume":"61","author":"Isogai","year":"2001","journal-title":"Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2014.1001271","article-title":"Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer","volume":"16","author":"Mashiko","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0219064","article-title":"Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis","volume":"14","author":"Alotaibi","year":"2019","journal-title":"PLoS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.fertnstert.2010.10.024","article-title":"Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia","volume":"95","author":"G\u00f3mez","year":"2011","journal-title":"Fertility Sterility"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.10.001","article-title":"SERPINE2\/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer","volume":"524","author":"Zhang","year":"2022","journal-title":"Cancer Lett"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12927","article-title":"Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages","volume":"7","author":"Smirnova","year":"2016","journal-title":"Oncotarget"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05566-w","article-title":"Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4573","article-title":"The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression","volume":"69","author":"Fayard","year":"2009","journal-title":"Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1477-7827-9-38","article-title":"SERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase","volume":"9","author":"Lee","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.fertnstert.2009.03.086","article-title":"Aberrant gene expression profile in a mouse model of endometriosis mirrors that observed in women","volume":"93","author":"Pelch","year":"2010","journal-title":"Fertility Sterility"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.214","article-title":"Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors","volume":"24","author":"Bijsmans","year":"2010","journal-title":"Modern Pathol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-022-00687-4","article-title":"Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin \u03b21\/FAK signaling pathway","volume":"45","author":"Song","year":"2022","journal-title":"Cell Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22773","article-title":"Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity","volume":"121","author":"Asanuma","year":"2007","journal-title":"Int J Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.2541","article-title":"Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors","volume":"23","author":"Sieben","year":"2005","journal-title":"J Clin Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.150","article-title":"Targeting JAK kinase in solid tumors: emerging opportunities and challenges","volume":"35","author":"Buchert","year":"2016","journal-title":"Oncogene"},{"key":"B80","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK\u2013STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"B81","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s43556-023-00151-1","article-title":"JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions","volume":"4","author":"Sarapultsev","year":"2023","journal-title":"Mol Biomedicine"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0119473","article-title":"Differential expression of lipid metabolism-related proteins in different breast cancer subtypes","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"362","DOI":"10.21037\/atm-20-2897","article-title":"SMURF1-mediated ubiquitylation of SHP-1 promotes cell proliferation and invasion of endometrial stromal cells in endometriosis","volume":"9","author":"Bian","year":"2021","journal-title":"Ann Transl Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918775","article-title":"Coagulation and complement: Key innate defense participants in a seamless web","volume":"13","author":"Pryzdial","year":"2022","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00846","article-title":"The mast cell, contact, and coagulation system connection in anaphylaxis","volume":"8","author":"Guilarte","year":"2017","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/gene.2010.35","article-title":"Mast cell homeostasis and the JAK\u2013STAT pathway","volume":"11","author":"Morales","year":"2010","journal-title":"Genes Immun"},{"key":"B88","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1600-0897.2007.00502.x","article-title":"Targeting mast cells in endometriosis with janus kinase 3 inhibitor, JANEX-1","volume":"58","author":"D\u2019cruz","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/CELLS10071759","article-title":"The role of coagulation and complement factors for mast cell activation in the pathogenesis of chronic spontaneous urticaria","volume":"10","author":"Yanase","year":"2021","journal-title":"Cells"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2243825","DOI":"10.1080\/07853890.2023.2243825","article-title":"Combined proteomics and transcriptomics identifies serpin family C member 1 associated protein as a biomarker of endometriosis","volume":"55","author":"Li","year":"2023","journal-title":"Ann Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa255","article-title":"Endometrial DNA damage response is modulated in endometriosis","volume":"36","author":"Bane","year":"2021","journal-title":"Hum Reprod"},{"key":"B92","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/S41597-020-00623-X","article-title":"A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions","volume":"7","author":"Gabriel","year":"2020","journal-title":"Sci Data"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/FGENE.2019.00766","article-title":"Machine learning classifiers for endometriosis using transcriptomics and methylomics data","volume":"10","author":"Akter","year":"2019","journal-title":"Front Genet"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24358","article-title":"Transcriptional profiling of endometriosis tissues identifies genes related to organogenesis defects","volume":"228","author":"Crispi","year":"2013","journal-title":"J Cell Physiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1477-7827-10-84","article-title":"Genome-wide expressions in autologous eutopic and ectopic endometrium of fertile women with endometriosis","volume":"10","author":"Khan","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-1692","article-title":"Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","volume":"148","author":"Burney","year":"2007","journal-title":"Endocrinology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0703451104","article-title":"Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator","volume":"104","author":"Hever","year":"2007","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1619434\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:29:04Z","timestamp":1751952544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1619434\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":97,"alternative-id":["10.3389\/fimmu.2025.1619434"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1619434","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1619434.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1619434.s002","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"article-number":"1619434"}}